Manulife (Manufacturers Life Insurance)
PACB icon

Manulife (Manufacturers Life Insurance)’s Pacific Biosciences PACB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.8K Sell
74,844
-7,683
-9% -$13.7K ﹤0.01% 2628
2025
Q4 		$154K Sell
82,527
-11,315
-12% -$21.7K ﹤0.01% 2616
2025
Q3 		$120K Sell
93,842
-7,072
-7% -$9.58K ﹤0.01% 2737
2025
Q2 		$125K Buy
100,914
+2,798
+3% +$3.23K ﹤0.01% 2711
2025
Q1 		$116K Sell
98,116
-194,343
-66% -$298K ﹤0.01% 2663
2024
Q4 		$535K Sell
292,459
-2,906
-1% -$5.67K ﹤0.01% 2202
2024
Q3 		$502K Sell
295,365
-34,450
-10% -$56.6K ﹤0.01% 2289
2024
Q2 		$452K Buy
329,815
+15,567
+5% +$31.4K ﹤0.01% 2259
2024
Q1 		$1.18M Sell
314,248
-12,229
-4% -$71.6K ﹤0.01% 1770
2023
Q4 		$3.2M Sell
326,477
-5,569
-2% -$45.5K ﹤0.01% 1328
2023
Q3 		$2.77M Buy
332,046
+48,740
+17% +$557K ﹤0.01% 1337
2023
Q2 		$3.77M Buy
283,306
+9,930
+4% +$121K ﹤0.01% 1212
2023
Q1 		$3.17M Buy
273,376
+20,047
+8% +$199K ﹤0.01% 1255
2022
Q4 		$2.09M Sell
253,329
-626
-0.2% -$5.39K ﹤0.01% 1367
2022
Q3 		$1.44M Sell
253,955
-2,897
-1% -$16.6K ﹤0.01% 1473
2022
Q2 		$1.16M Buy
256,852
+10,710
+4% +$65.1K ﹤0.01% 1587
2022
Q1 		$2.33M Buy
246,142
+147,698
+150% +$1.7M ﹤0.01% 1461
2021
Q4 		$2.04K Sell
98,444
-254
-0.3% -$6.13K ﹤0.01% 1495
2021
Q3 		$2.52M Sell
98,698
-9,616
-9% -$285K ﹤0.01% 1444
2021
Q2 		$3.79M Buy
108,314
+6,749
+7% +$196K ﹤0.01% 1393
2021
Q1 		$3.38M Sell
101,565
-3,262
-3% -$114K ﹤0.01% 1389
2020
Q4 		$2.72M Buy
104,827
+10,149
+11% +$172K ﹤0.01% 1428
2020
Q3 		$934K Buy
94,678
+6,292
+7% +$36.2K ﹤0.01% 1690
2020
Q2 		$305K Sell
88,386
-4,019
-4% -$13.7K ﹤0.01% 2243
2020
Q1 		$283K Buy
92,405
+6,432
+7% +$26.3K ﹤0.01% 2127
2019
Q4 		$442K Sell
85,973
-2,183
-2% -$11.1K ﹤0.01% 2122
2019
Q3 		$460K Sell
88,156
-139
-0.2% -$777 ﹤0.01% 2070
2019
Q2 		$534K Sell
88,295
-1,636
-2% -$11.5K ﹤0.01% 2012
2019
Q1 		$650K Buy
89,931
+9,126
+11% +$66K ﹤0.01% 1927
2018
Q4 		$598K Sell
80,805
-1,362
-2% -$8.63K ﹤0.01% 1867
2018
Q3 		$445K Sell
82,167
-13,174
-14% -$56.5K ﹤0.01% 2371
2018
Q2 		$338K Buy
95,341
+3,418
+4% +$9.48K ﹤0.01% 2691
2018
Q1 		$189K Buy
91,923
+7,743
+9% +$20.1K ﹤0.01% 3061
2017
Q4 		$223K Buy
84,180
+2,147
+3% +$7.52K ﹤0.01% 2917
2017
Q3 		$431K Buy
82,033
+11,500
+16% +$49.4K ﹤0.01% 2380
2017
Q2 		$250K Buy
70,533
+5,145
+8% +$20.7K ﹤0.01% 2829
2017
Q1 		$339K Buy
65,388
+9,030
+16% +$44.2K ﹤0.01% 2460
2016
Q4 		$215K Buy
56,358
+3,669
+7% +$26.7K ﹤0.01% 2727
2016
Q3 		$473K Sell
52,689
-679
-1% -$5.68K ﹤0.01% 2121
2016
Q2 		$376K Buy
53,368
+11,920
+29% +$109K ﹤0.01% 2221
2016
Q1 		$362K Sell
41,448
-2,777
-6% -$27.3K ﹤0.01% 2189
2015
Q4 		$580 Buy
44,225
+420
+1% +$3.77K ﹤0.01% 1931
2015
Q3 		$161 Buy
43,805
+445
+1% +$2.18K ﹤0.01% 2821
2015
Q2 		$250 Buy
43,360
+3,975
+10% +$23K ﹤0.01% 2675
2015
Q1 		$230 Buy
39,385
+1,484
+4% +$10.2K ﹤0.01% 2630
2014
Q4 		$297 Sell
37,901
-547
-1% -$3.5K ﹤0.01% 2357
2014
Q3 		$189 Buy
38,448
+157
+0.4% +$821 ﹤0.01% 2679
2014
Q2 		$237K Buy
38,291
+135
+0.4% +$676 ﹤0.01% 2597
2014
Q1 		$204 Sell
38,156
-1,386
-4% -$8.76K ﹤0.01% 2699
2013
Q4 		$207 Buy
39,542
+38,142
+2,724% +$175K ﹤0.01% 2694
2013
Q3 		$8 Buy
1,400
+440
+46% +$1.53K ﹤0.01% 3289
2013
Q2 		$2K Buy
+960
New +$2.39K ﹤0.01% 3411

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PACB Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Pacific Biosciences (PACB) stake by 9.3% in Q1 2026, selling an estimated $13.7K and leaving 74,844 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

Manulife (Manufacturers Life Insurance) first reported a position in PACB in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.79M in Q2 2021. 230 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 74,844 shares of Pacific Biosciences worth $98.8K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 7,683 Pacific Biosciences shares in Q1 2026, an estimated $13.7K.
  • Pacific Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2628 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pacific Biosciences in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Pacific Biosciences position peaked at $3.79M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.